Table 8 | Cases of HIV Infection and AIDS in the United States, by Race/Ethnicity, 1998–2002 | Reports | Statistics and Surveillance | Topics

Home

About CDC

Press Room

A-Z Index

CDC en Español

CDC Home > HIV/AIDS > Topics > Statistics and Surveillance > Reports > Cases of HIV Infection and AIDS in the United States, by Race/Ethnicity, 1998–2002

Table 8. Estimated numbers of persons living with HIV infection (not AIDS), by race/ethnicity, sex, exposure category, and age category at diagnosis, 1999–2002—30 areas with confidential name-based HIV infection reporting

View PDF


Exposure category	1999	2000	2001	2002
	White, not Hispanic
Male adult or adolescent
Male-to-male sexual contact	27,357	29,049	30,897	32,941
Injection drug use	3,812	3,938	4,059	4,199
Male-to-male sexual contact and injection drug use	3,708	3,748	3,786	3,832
Heterosexual contact	1,598	1,719	1,861	1,999
Other^a	489	495	501	507
Subtotal	36,964	38,949	41,104	43,479

Female adult or adolescent
Injection drug use	2,671	2,821	2,935	3,054
Heterosexual contact	4,798	5,228	5,671	6,074
Other^a	148	150	153	163
Subtotal	7,617	8,200	8,759	9,292

Total adults and adolescents	44,581	47,149	49,863	52,770

Child (<13 yrs)
Perinatal	250	262	280	295
Other^a	100	98	94	80
Subtotal	350	360	374	375
Total	44,931	47,509	50,237	53,145

	Black, not Hispanic
Male adult or adolescent
Male-to-male sexual contact	17,804	19,144	20,494	21,941
Injection drug use	9,411	9,612	9,730	9,914
Male-to-male sexual contact and injection drug use	2,853	2,879	2,890	2,896
Heterosexual contact	7,859	8,757	9,605	10,380
Other^a	349	365	388	397
Subtotal	38,276	40,757	43,108	45,528

Female adult or adolescent
Injection drug use	5,526	5,685	5,847	5,974
Heterosexual contact	16,099	18,031	19,870	21,800
Other^a	352	385	396	415
Subtotal	21,977	24,101	26,114	28,189

Total adults and adolescents	60,253	64,858	69,221	73,717

Child (<13 yrs)
Perinatal	947	1,020	1,107	1,171
Other^a	113	111	101	100
Subtotal	1,061	1,131	1,208	1,271
Total	61,313	65,989	70,429	74,988

	Hispanic
Male adult or adolescent
Male-to-male sexual contact	3,668	4,227	4,791	5,561
Injection drug use	1,848	1,929	2,032	2,134
Male-to-male sexual contact and injection drug use	483	519	543	553
Heterosexual contact	901	1,076	1,235	1,404
Other^a	48	56	65	68
Subtotal	6,949	7,807	8,665	9,720

Female adult or adolescent
Injection drug use	670	713	733	755
Heterosexual contact	1,580	1,812	2,057	2,346
Other^a	37	44	50	59
Subtotal	2,287	2,569	2,840	3,160

Total adults and adolescents	9,236	10,376	11,506	12,880

Child (<13 yrs)
Perinatal	128	141	163	173
Other^a	20	20	19	16
Subtotal	148	161	182	189
Total	9,384	10,537	11,688	13,069

	Asian/Pacific Islander
Male adult or adolescent
Male-to-male sexual contact	208	249	275	313
Injection drug use	35	44	53	64
Male-to-male sexual contact and injection drug use	14	16	19	20
Heterosexual contact	41	47	55	66
Other^a	4	5	4	5
Subtotal	301	361	405	468

Female adult or adolescent
Injection drug use	19	22	25	25
Heterosexual contact	90	101	116	132
Other^a	2	2	4	5
Subtotal	111	125	145	162

Total adults and adolescents	412	486	551	630

Child (<13 yrs)
Perinatal	7	7	7	9
Other^a	5	5	5	5
Subtotal	12	12	12	14
Total	424	498	563	644

	American Indian/Alaska Native
Male adult or adolescent
Male-to-male sexual contact	319	336	359	373
Injection drug use	87	87	86	86
Male-to-male sexual contact and injection drug use	86	90	84	85
Heterosexual contact	40	46	47	51
Other^a	2	2	2	3
Subtotal	535	562	578	597

Female adult or adolescent
Injection drug use	69	73	74	79
Heterosexual contact	108	120	128	141
Other^a	1	1	1	1
Subtotal	178	193	203	220

Total adults and adolescents	712	755	781	818

Child (<13 yrs)
Perinatal	8	8	8	9
Other^a	3	3	3	3
Subtotal	11	11	11	12
Total	723	766	792	830
Total cases^b	117,844	126,541	135,141	144,129

Note. These numbers do not represent actual cases in persons living with HIV infection (not AIDS). Rather, these numbers are point estimates of persons living with HIV infection(not AIDS) that have been adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk. The estimates have not been adjusted for incomplete reporting. Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.

Since 1998, the following 30 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Arkansas, Arizona, Florida, Colorado, Iowa, Idaho, Indiana, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, Nevada, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, Virginia, Wisconsin, West Virginia, Wyoming, and the U.S. Virgin Islands. Since July 1997, Florida has had confidential name-based HIV infection reporting only for new diagnoses.


^a	Includes hemophilia, blood transfusion, and risk not reported or not identified.
^b	Includes persons of unknown race or multiple races and persons of unknown sex.

Last Modified: June 14, 2006
Last Reviewed: June 14, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Home

Policies and Regulations

Disclaimer

e-Government

FOIA

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.

Department of Health
and Human Services